Epratuzumab: targeting B-cell malignancies through CD22 (Q35541773)
Jump to navigation
Jump to search
scientific article published on September 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epratuzumab: targeting B-cell malignancies through CD22 |
scientific article published on September 1, 2003 |
Statements
Epratuzumab: targeting B-cell malignancies through CD22 (English)
Morton Coleman
Michelle Ashe
David M. Goldenberg
Abby B. Siegel
Jamie C. Ketas
Jennifer M. Fiore
1 September 2003